Joris de Bie

Joris de Bie, MBS, PhD, currently serves as the Head of Early Clinical Development at Chugai Pharmaceutical Co., Ltd., overseeing early clinical studies across the US therapeutic areas and chairing the Global Study Management platform. With extensive experience in clinical operations and management, Joris has held significant leadership roles at several pharmaceutical companies, including VP of Clinical Operations at Mesoblast Ltd and Head of Global Trial Optimization at Merck & Co. Additionally, Joris was a Senior Director at both Schering-Plough and Organon USA, managing large teams focused on clinical development in various therapeutic areas. Joris holds a PhD from Utrecht University and has pursued further education at institutions such as Cornell University and Yale School of Medicine.